Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer

Stock Information for Assertio Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Assertio Holdings Inc.

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
Assertio Reports Third Quarter 2024 Financial Results
Assertio Provides Response to Letter from Short-seller
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.